Timing meals during cancer treatment for Alaska Native patients
Part of Cancer, Digestive system, Skin clinical trials.
This study tests whether scheduling meals at specific times of day can improve how patients feel during cancer treatment. It is for Alaska Native or American Indian people with certain cancers (rectal, HER2+ or triple negative breast, or other solid tumors) who are receiving neoadjuvant (before surgery) or adjuvant (after surgery) therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are Alaska Native or American Indian and get care at Alaska Native Medical Center (ANMC).
- You are 21 or older.
- You have one of these cancers: rectal cancer (stage II, III, or IV), HER2+ or triple negative breast cancer (stage I, II, or III), or another solid tumor that can be treated after surgery.
- You plan to start or have already started neoadjuvant or adjuvant therapy within the last 4 weeks, and your treatment will last more than 3 months.
- You do not have serious heart failure, nerve damage, or other major health issues listed in the exclusion criteria.
- You are not doing overnight shift work more than 1 day per week, and you are not already eating all your meals within a 10-hour window each day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a personalized exercise and nutrition program before rectal cancer surgery can help you recover faster and have fewer complications. If you are not very active right now, you may be able to join.
This study looks at how the timing of meals during cancer treatment recovery affects how well you tolerate and respond to your therapy. Researchers want to learn whether eating during certain hours of the day might help your body handle chemotherapy, targeted drugs, or immunotherapy better.
This study tests whether eating only within a shorter daily time window can improve cancer outcomes in people with specific breast or rectal cancers. It also looks at how this affects the body (such as metabolism) and who is most likely to benefit.
This trial tests whether eating only during certain hours of the day (time-restricted eating) is doable and helpful for people receiving chemotherapy for breast cancer. The goal is to see if this eating pattern can be a safe way to support your health during treatment.
This trial studies whether time-restricted eating (eating only within certain hours) during breast cancer chemotherapy is safe and helpful. Researchers want to see if it improves chemotherapy outcomes and side effects for people with stage I–III breast cancer.
This study tests whether eating only during a certain window of time each day (time-restricted eating) can improve outcomes for people with early-stage breast cancer who are getting chemotherapy before surgery. It may help with treatment side effects and overall health.
Hear when a new Rectal Cancer Stage II trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.